Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd Ordinary Shares (BMGL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BMGL · as of Sep 30, 2025
Ownership Breakdown
9
Institutional Holders
▲ 3 vs Q2
$524,583
Total Inst. Value
▲ $303,408 vs Q2
18.79M
Shares Outstanding
freeFloat 27.85%
289,472
13F Shares Held
▲ 165,132 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BMGL largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CITADEL ADVISORS LLC services-offices & clinics of doctors of medicine | 93.0K | 49.60% | 49.60% | $169.25M | Nov 14, 2025 | NEW |
MORGAN STANLEY services-offices & clinics of doctors of medicine | 74.3K | 39.62% | 39.62% | $135.21M | May 27, 2026 | NEW |
MAREX GROUP PLC services-offices & clinics of doctors of medicine | 58.9K | 31.42% | 31.42% | $105.45M | Nov 14, 2025 | ▲ 45.0K |
VIRTU FINANCIAL LLC services-offices & clinics of doctors of medicine | 33.8K | 18.02% | 18.02% | $61.00M | Nov 14, 2025 | ▲ 17.6K |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC services-offices & clinics of doctors of medicine | 22.1K | 11.79% | 11.79% | $40.23M | Oct 31, 2025 | NEW |
UBS GROUP AG services-offices & clinics of doctors of medicine | 5.9K | 3.15% | 3.15% | $10.74M | Nov 13, 2025 | ▲ 255 |
WEALTHCOLLAB, LLC services-offices & clinics of doctors of medicine | 953 | 0.51% | 0.51% | $1.74M | Nov 13, 2025 | NEW |
EVERSOURCE WEALTH ADVISORS, LLC services-offices & clinics of doctors of medicine | 277 | 0.15% | 0.15% | $504,000 | Nov 10, 2025 | NEW |
BELL INVESTMENT ADVISORS, INC services-offices & clinics of doctors of medicine | 248 | 0.13% | 0.13% | $452,000 | Nov 21, 2025 | NEW |
TOWER RESEARCH CAPITAL LLC (TRC) services-offices & clinics of doctors of medicine | 0 | 0.00% | 0.00% | $0 | Nov 14, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
3
Increased
+62.9K shares6
New Positions
first time holders0
Decreased
−0 shares3
Sold Out
fully exitedNet shares change (top 50)
+62.9K
+62.9K / −0
Net new holders
+6
6 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BMGL insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Basel Medical Group Ltd Ordinary Shares (BMGL) is primarily owned by institutional investors, who hold approximately 1.5% of total shares outstanding. Company insiders own approximately 72.15%, while retail and public investors account for the remaining 26.31%.
The largest institutional shareholder of Basel Medical Group Ltd Ordinary Shares is CITADEL ADVISORS LLC, holding approximately 92,997 shares — equal to 49.60% of outstanding shares — as of September 30, 2025.
A total of 9 institutional investors currently hold BMGL stock, with a combined institutional value of approximately $524,583 as of the most recent 13F filing period.
Frequently asked questions
BMGL ownershipBasel Medical Group Ltd Ordinary Shares (BMGL) is primarily owned by institutional investors, who hold approximately 1.5% of shares. The largest shareholder is CITADEL ADVISORS LLC with a 49.60% stake. Company insiders hold 72.15%. Data sourced from SEC Form 13F as of September 30, 2025.